Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals Plc

BDRX
Biodexa Pharmaceuticals PlcUS flagNASDAQ Capital Market
1.77
USD
-0.36
- -
1.32MMarket Cap

Biodexa Pharmaceuticals Plc (BDRX) Stock Split History

Learn about Biodexa Pharmaceuticals Plc's most recent 1-for-5 basis stock split on April 06, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Biodexa Pharmaceuticals Plc's most recent stock split

Split Date: 2026-04-06
Split Ratio: 1:5
Price Before Split: $0.77
Price After Split: $0.15

Developer API

Get BDRX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/BDRX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 5.00 times fewer shares (a 1:5 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Biodexa Pharmaceuticals Plc's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-04-061:5Yes$0.77$0.15
2025-07-311:10Yes$0.16$0.02
2024-10-041:25Yes$0.04$0.00
2023-07-051:80Yes$0.01$0.00
2023-03-271:4Yes$0.02$0.01
2022-09-261:5Yes$0.10$0.02
2020-03-031:5Yes$0.11$0.02
2019-04-081:10Yes$0.05$0.01
2018-01-02507:500No$2981160000000000.00$2940000000000000.00

About Biodexa Pharmaceuticals Plc

Company overview and industry information

Biodexa Pharmaceuticals Plc (BDRX) operates in the Biotechnology industry. The recent 1-for-5 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Biodexa Pharmaceuticals Plc Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.